Novartis Ag (NVS) Return on Assets (2009 - 2010)
Novartis Ag (NVS) posted Return on Assets of 0.0% for Q1 2010, down 100.0% sequentially from 0.0% in Q4 2009, and little changed YoY from 0.0% in Q1 2009.
Novartis Ag (NVS) Return on Assets (2009 - 2010) Analysis & Trends
Novartis Ag has reported Return on Assets for 2 years, with the latest figure at 0.0% in Q1 2010.
- Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2010, while the trailing twelve-month figure through Mar 2010 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Assets eased to 0.0% in Q1 2010 per NVS's latest filing, from 0.0% in the prior quarter.
- Over five years, Return on Assets peaked at 0.0% in Q3 2009 and troughed at 0.0% in Q1 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 0.00% |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 0.00% |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 0.00% |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 0.00% |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 0.00% |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 0.00% |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 0.00% |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 0.00% |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2010 | 0.00% |
| Dec 31, 2009 | 0.00% |
| Sep 30, 2009 | 0.00% |
| Jun 30, 2009 | 0.00% |
| Mar 31, 2009 | 0.00% |